ARS Pharmaceuticals Newsroom

ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies

BenzingaDec 19 17:29 ET

ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies

GlobeNewswireDec 19 17:25 ET

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18 08:00 ET

Ars Pharmaceuticals Insider Sold Shares Worth $657,625, According to a Recent SEC Filing

MT NewswiresDec 12 17:47 ET

ARS Pharmaceuticals Files for Approval of Neffy in China, Japan and Australia

TipRanksDec 12 14:40 ET

Express News | ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia

BenzingaDec 12 14:35 ET

Express News | Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.02 Million in Common Stocks

Moomoo NewsDec 10 11:20 ET

ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

SECDec 6 16:10 ET · Announcements

Insider Sale: Director at $SPRY (SPRY) Sells 14,772 Shares

Quiver QuantitativeDec 4 21:45 ET

ARS Pharmaceuticals Announces That It Will Be Launching The NeffyinSchools Program In January 2025; The Program Will Provide Eligible Public And Private K-12 Schools In The U.S. The Opportunity To Receive Two Cartons Of Neffy 2mg For Use In Emergency...

BenzingaDec 4 08:19 ET

ARS Pharmaceuticals Announces Planned Launch of NeffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost

GlobeNewswireDec 4 08:00 ET

Trade Alert: Chief Business Officer & Secretary Of ARS Pharmaceuticals Justin Chakma Has Sold Stock

Simply Wall StNov 30 07:05 ET

Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.09 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 15, $ARS Pharmaceuticals(SPRY.US)$ Officer Chakma Justin intends to sell 236.38K shares of its common stock on Nov 15, with a total market value of approximately $4.09

Moomoo NewsNov 15 15:24 ET

Express News | Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties

ReutersNov 14 09:00 ET

ARS Pharmaceuticals Insider Sold Shares Worth $10,143,706, According to a Recent SEC Filing

MT NewswiresNov 14 03:18 ET

Express News | ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $26 From $25

ReutersNov 14 02:58 ET

ARS Pharmaceuticals' Strong Q3 2024 Highlights

TipRanksNov 13 23:15 ET

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$10.14 Million in Common Stock

Moomoo NewsNov 13 20:19 ET

ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 13 12:56 ET · Conference Call

Express News | ARS Pharmaceuticals Shares Are Higher Lower After the Company Reported Better-than-expected Q3 Sales Results

BenzingaNov 13 08:05 ET